HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 5.50
Day range
kr 5.51 - kr 5.98
Year range
kr 3.03 - kr 7.07
Market cap
2.30B SEK
Avg Volume
886.32K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 17.80M | 64.81% |
Operating expense | 114.60M | 8.63% |
Net income | -119.70M | -8.33% |
Net profit margin | -672.47 | 34.27% |
Earnings per share | -0.30 | 0.00% |
EBITDA | -110.15M | -13.88% |
Effective tax rate | -0.34% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 215.80M | -38.52% |
Total assets | 639.10M | -19.34% |
Total liabilities | 300.40M | 0.33% |
Total equity | 338.70M | — |
Shares outstanding | 395.16M | — |
Price to book | 6.40 | — |
Return on assets | -44.77% | — |
Return on capital | -69.65% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -119.70M | -8.33% |
Cash from operations | -92.80M | -73.13% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 163.70M | -39.99% |
Net change in cash | 70.10M | -68.29% |
Free cash flow | -44.84M | -226.39% |
About
Founded
2006
Website
Employees
40
